Clinical trial
Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema
NCT00958906 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- August 31, 2009
- Completion date
- October 31, 2009
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intraocular inflammation, uveitic macular edema